A group of scientists in the Netherlands created robotic legs to try improving the movements of stroke patients.
The Lower-extremity Powered Exoskeleton or LOPES works by training the body and mind to recover a more natural step and it is hoped to have a commercial version made available to rehabilitation centers around the world.
Experts believe the possibilities are diverse and it hopes therapeutic advances to aid human performance of stroke victims.
The first clinical trial using human embryonic stem cells have been given consent to carry out have been initialized at Moorfields Eye Hospital.
They will introduce retinal cells into the eyes of twelve patients with an untreatable disease, Stargardt’s macular dystrophy, which causes progressive vision loss that affects one in 10,000 people around the world.
The trial test will test the safety of using substitute retinal cells identified as retinal pigment epithelial cells which are obtained from human embryo embryonic stem cells.